Wednesday
SESSION 30: NEW CONCEPTS, DIFFERING VIEWPOINTS, CONTROVERSIES IN VASCULAR DISEASE AND ITS TREATMENT
Moderators:Enrico Ascher, MD / Herbert Dardik, MD  
SESSION 30 SCHEDULE
1:00 PM - 1:05 PM Appropriate Genome-Based Antiplatelet Treatment Should Be A Prerequisite For All Interventional Treatments
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Abstract      
1:06 PM - 1:11 PM Combined Anatomic-Functional Testing With Coronary CT Angiography And Functional Flow Dynamics Is A Game Changer In Evaluating Cardiac Status In Vascular Patients: It Will Replace All Other Diagnostic Tests
  Presenter(s):Christopher K. Zarins, MD  
  View Abstract      
1:12 PM - 1:17 PM Value Of Biomarkers For Arteriosclerosis In Predicting Cardiac Risk In Vascular Patients
  Presenter(s):Peter Henke, MD  
  View Abstract      
1:18 PM - 1:23 PM Monocyte Phenotyping: A Sensitive Biomarker For Predicting Adverse Vascular Events
  Presenter(s):John P. Fletcher, MD  
  View Abstract      
1:24 PM - 1:29 PM Update On The RCT Of Venous Balloon Angioplasty Of Venous Balloon Angioplasty vs. Venography Placebo: What Does It Tell Us
  Presenter(s):L. Nelson Hopkins, MD  
  View Abstract      
1:30 PM - 1:35 PM What Is SPY Technology And How Can It Help Vascular Specialists And Vascular Patients
  Presenter(s):Wei Zhou, MD  
  View Abstract      
1:36 PM - 1:41 PM DEBATE: Off Label Use Of EVAR Devices Leads To Higher Failure Rates
  Presenter(s):Andres Schanzer, MD  
  View Abstract      
1:42 PM - 1:47 PM DEBATE: Not So! Off-Label Use Of Newer EVAR Devices Does Not Lead To Higher Failure Rates: Why The Discrepancy
  Presenter(s):B. Patrice Mwipatayi, FRACS  
  View Abstract      
1:48 PM - 1:53 PM Saccular AAAs Behave Differently From Fusiform AAAs Of The Same Diameter: How Should It Influence Our Treatment: Is There Proof
  Presenter(s):Jacques Busquet, MD  
  View Abstract      
1:54 PM - 1:59 PM DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Interventionalist’s Point Of View
  Presenter(s):Craig M. Walker, MD  
  View Abstract      
2:00 PM - 2:05 PM DEBATE: How Far Should We Go With Endovascular Treatment Of Challenging CTOs Causing CLI: An Endocompetent Vascular Surgeon’s View
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Abstract      
2:06 PM - 2:13 PM Panel Discussion
END OF SESSION 30
previous next